Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance

American Journal of Cardiology

Volumn 113, Issue 8, 2014, Pages 1394-1400

  Maron, Barry J ^a   Haas, Tammy S ^a   Maron, Martin S ^b   Lesser, John R ^a   Browning, Joseph A ^a   Chan, Raymond H ^c,d   Olivotto, Iacopo ^e   Garberich, Ross F ^a   Schwartz, Robert S ^a  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d Data Coordinating Center   (United States)

^e CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DETERIORATION; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM REMODELING; HEART EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINUS RHYTHM;

ADULT; ATRIAL FIBRILLATION; ATRIAL FUNCTION, LEFT; ATRIAL REMODELING; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84897463416     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.12.045     Document Type: Article

References (30)

1. B.J. Maron, and M.S. Maron Hypertrophic cardiomyopathy Lancet 381 2013 242 255
2. B.J. Maron, I. Olivotto, P. Bellone, M.R. Conte, F. Cecchi, B.P. Flygenring, S.A. Casey, T.E. Gohman, S. Bongioanni, and P. Spirito Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy J Am Coll Cardiol 39 2002 301 307
3. S. Nistri, I. Olivotto, S. Betocchi, M.A. Losi, G. Valsecchi, B. Pinamonti, M.R. Conte, F. Casazza, M. Galderisi, B.J. Maron, and F. Cecchi Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy) Am J Cardiol 98 2006 960 965
4. I. Olivotto, F. Cecchi, S.A. Casey, A. Dolara, J.H. Traverse, and B.J. Maron Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy Circulation 104 2001 2517 2524
5. B.J. Gersh, B.J. Maron, R.O. Bonow, J.A. Dearani, M.A. Fifer, M.S. Link, S.S. Naidu, R.A. Nishimura, S.R. Ommen, H. Rakowski, C.E. Seidman, J.A. Towbin, J.E. Udelson, and C.W. Yancy 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Thorac Cardiovasc Surg 142 2011 e153 e203
6. B.J. Maron Hypertrophic cardiomyopathy: a systematic review JAMA 287 2002 1308 1320
7. B.J. Maron, W.J. McKenna, G.K. Danielson, L.J. Kappenberger, H.J. Kuhn, C.E. Seidman, P.M. Shah, W.H. Spencer III, P. Spirito, F.J. Ten Cate, E.D. Wigle, and Task Force on Clinical Expert Consensus Documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J Am Coll Cardiol 42 2003 1687 1713
8. C. Girasis, V. Vassilikos, G.K. Efthimiadis, S.L. Papadopoulou, G. Dakos, E.G. Dalamaga, I. Chouvarda, G. Giannakoulas, V. Kamperidis, S. Paraskevaidis, N. Maglaveras, H.I. Karvounis, G.E. Parcharidis, and I.H. Styliadis Patients with hypertrophic cardiomyopathy at risk for paroxysmal atrial fibrillation: advanced echocardiographic evaluation of the left atrium combined with non-invasive p-wave analysis Eur Heart J Cardiovasc Imaging 14 2013 425 434
9. M.A. Losi, S. Betocchi, M. Aversa, R. Lombardi, M. Miranda, G. D'Alessandro, A. Cacace, C.G. Tocchetti, G. Barbati, and M. Chiariello Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy Am J Cardiol 94 2004 895 900
10. V. Sachdev, Y. Shizukuda, C.L. Brenneman, C.W. Birdsall, M.A. Waclawiw, A.E. Arai, S.A. Mohiddin, D. Tripodi, L. Fananapazir, and J.F. Plehn Left atrial volumetric remodeling is predictive of functional capacity in nonobstructive hypertrophic cardiomyopathy Am Heart J 149 2005 730 736
11. T. Tani, K. Tanabe, M. Ono, K. Yamaguchi, M. Okada, T. Sumida, T. Konda, Y. Fujii, J. Kawai, T. Yagi, M. Sato, M. Ibuki, M. Katayama, K. Tamita, K. Yamabe, A. Yamamuro, K. Nagai, K. Shiratori, and S. Morioka Left atrial volume and the risk of paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy J Am Soc Echocardiogr 17 2004 644 648
12. J.L. Anderson, B.D. Horne, and D.J. Pennell Atrial dimensions in health and left ventricular disease using cardiovascular magnetic resonance J Cardiovasc Magn Reson 7 2005 671 675
13. L.E. Hudsmith, A.S. Cheng, D.J. Tyler, C. Shirodaria, J. Lee, S.E. Petersen, J.M. Francis, K. Clarke, M.D. Robson, and S. Neubauer Assessment of left atrial volumes at 1.5 Tesla and 3 Tesla using FLASH and SSFP cine imaging J Cardiovasc Magn Reson 9 2007 673 679
14. L.E. Hudsmith, S.E. Petersen, J.M. Francis, M.D. Robson, and S. Neubauer Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging J Cardiovasc Magn Reson 7 2005 775 782
15. B. Sievers, S. Kirchberg, M. Addo, A. Bakan, B. Brandts, and H.J. Trappe Assessment of left atrial volumes in sinus rhythm and atrial fibrillation using the biplane area-length method and cardiovascular magnetic resonance imaging with TrueFISP J Cardiovasc Magn Reson 6 2004 855 863
16. J.T. Kühl, K.F. Kofoed, J.E. Møller, S. Hammer-Hansen, T. Kristensen, L. Køber, and H. Kelbæk Assessment of left atrial volume and mechanical function in ischemic heart disease a multi slice computed tomography study Int J Cardiol 145 2010 197 202
17. A.M. Maceira, J. Cosin-Sales, M. Roughton, S.K. Prasad, and D.J. Pennell Reference left atrial dimensions and volumes by steady state free precession cardiovascular magnetic resonance J Cardiovasc Magn Reson 12 2010 65
18. M. Whitlock, A. Garg, J. Gelow, T. Jacobson, and C. Broberg Comparison of left and right atrial volume by echocardiography versus cardiac magnetic resonance imaging using the area-length method Am J Cardiol 106 2010 1345 1350
19. M.S. Maron, E. Appelbaum, C.J. Harrigan, J. Buros, C.M. Gibson, C. Hanna, J.R. Lesser, J.E. Udelson, W.J. Manning, and B.J. Maron Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy Circ Heart Fail 1 2008 184 191
20. B.J. Maron, M.S. Maron, and C. Semsarian Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. (State-of the-art) J Am Coll Cardiol 60 2012 705 715
21. W.J. Youden Index for rating diagnostic tests Cancer 3 1950 32 35
22. T. Papavassiliu, T. Germans, S. Flüchter, C. Doesch, A. Suriyakamar, D. Haghi, T. Süselbeck, C. Wolpert, D. Dinter, S.O. Schoenberg, A.C. van Rossum, and M. Borggrefe CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation J Cardiovasc Magn Reson 11 2009 34
23. W.I. Yang, C.Y. Shim, Y.J. Kim, S.A. Kim, S.J. Rhee, E.Y. Choi, D. Choi, Y. Jang, N. Chung, S.Y. Cho, and J.W. Ha Left atrial volume index: a predictor of adverse outcome in patients with hypertrophic cardiomyopathy J Am Soc Echocardiogr 22 2009 1338 1343
24. M.S. Maron, B.J. Maron, C. Harrigan, J. Buros, C.M. Gibson, I. Olivotto, L. Biller, J.R. Lesser, J.E. Udelson, W.J. Manning, and E. Appelbaum Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance J Am Coll Cardiol 54 2009 220 228
25. M.S. Maron, J.J. Finley, J.M. Bos, T.H. Hauser, W.J. Manning, T.S. Haas, J.R. Lesser, J.E. Udelson, M.J. Ackerman, and B.J. Maron Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy Circulation 118 2008 1541 1549
26. R.H. Chan, B.J. Maron, I. Olivotto, G. Assenza, M.S. Hong, J. Lesser, T.S. Haas, C. Gruner, A. Crean, H. Rakowski, J. Udelson, E. Rowin, B. Tomberli, P. Spirito, F. Formisano, E. Biagini, C. Rapezzi, C.N. De Cecco, C. Autore, E.F. Cook, T. Hauser, C.M. Gibson, W. Manning, E. Appelbaum, and M.S. Maron Prognostic utility of contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: an international multicenter study (abstract) J Am Coll Cardiol 59 2012 E1570
27. M.S. Maron, I. Olivotto, C. Harrigan, E. Appelbaum, B.J. Gibson, J.R. Lesser, T.S. Haas, J.E. Udelson, W.J. Manning, and B.J. Maron Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy Circulation 124 2011 40 47
28. M. Anile, V. Telha, D. Diso, T. De Giacomo, S. Sciomer, E.A. Rendina, G.F. Coloni, and F. Venuta Left atrial size predicts the onset of atrial fibrillation after major pulmonary resections Eur J Cardiothorac Surg 41 2012 1094 1097
29. K. Wachtell, E. Gerdts, G.P. Aurigemma, K. Boman, B. Dahlöf, M.S. Nieminen, M.H. Olsen, P.M. Okin, V. Palmieri, J.E. Rokkedal, and R.B. Devereux In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: the LIFE Study Blood Press 19 2010 169 175
30. E.J. Benjamin, R.B. D'Agostino, A.J. Belanger, P.A. Wolf, and D. Levy Left atrial size and the risk of stroke and death. The Framingham Heart Study Circulation 92 1995 835 841